About Gerry Pencer
In 1987, Gerry Pencer, the CEO of the world’s largest private label soft drink maker, was diagnosed with a grade 4 Glioblastoma Multiforme brain tumour. During the course of his illness, Gerry sought information, answers, treatment options, and support systems for both himself and his family.
When he discovered the lack of readily available resources for brain tumour patients, Gerry Pencer set out to change the system. And like everything he did, he was determined to do it big. It was Gerry’s dream to fund and establish a world-class brain tumour centre where patients could feel at home while receiving state-of-the-art treatment and support, and where leading edge research could be encouraged. In November 1998, The Gerry & Nancy Pencer Brain Tumour Centre opened its doors on the 18th floor of Toronto’s Princess Margaret Cancer Centre and Gerry’s dream was realized.
The Pencer Centre has blossomed into North America’s foremost multidisciplinary brain tumour facility, treating and supporting over 5,200 patients and their families every year and performing groundbreaking research in search of a cure. The programs at The Pencer Centre are so innovative that we regularly receive personal visits from other hospitals and treatment facilities world-wide seeking to implement our model.
In addition, The Pencer Centre serves as a hub for brain tumour clinical trials in North America. In the summer of 2004, The Pencer Centre, led by esteemed Medical Director Dr. Warren Mason, was on the front lines of a ground-breaking discovery in the treatment of the most deadly type of brain tumour, Glioblastoma Multiforme. A new combination of drugs has been shown to dramatically improve the prognosis for newly-diagnosed patients. For the first time in over 30 years, there is new hope for brain tumour patients at The Pencer Centre and around the world!